Retrospective analysis shows significant improvement in emotional dysregulation in patients with ADHD and borderline personality disorder, indicating potential treatment benefits.
Key Points
Methylphenidate significantly reduced emotional dysregulation in patients with comorbid ADHD and BPD.
Statistically significant improvements in NED and C-T-Score were observed by week 4 of treatment.
This retrospective observational study evaluated 24 patients, with promising results suggesting further research is warranted.
The findings indicate Methylphenidate's potential role in addressing emotional impulsivity and lability in complex psychiatric conditions.